These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 448961)

  • 1. Digoxin-prescribing. Mostly good news.
    Weintraub M; Karch FE; Morgan JP; Trabert N; Sorensen A; Becker LA; Lasagna L
    JAMA; 1979 Aug; 242(5):445-8. PubMed ID: 448961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brand versus generic prescribing: a perspective of the Indian cardiologists' viewpoint.
    Bansinath M; Sequeira RP; Shukla VK; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):279-83. PubMed ID: 6746151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of steady-state serum concentrations of digoxin in tablets (Lanoxin) and capsules (Lanoxicaps) in the elderly.
    Pouwels MJ; Hooymans PM; van der Aa GC; Gribnau FW
    DICP; 1991 Oct; 25(10):1043-6. PubMed ID: 1803786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin prescribing in general practice 1967--77.
    Pedoe HD
    Lancet; 1978 Oct; 2(8096):931-3. PubMed ID: 81940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers.
    Bansinath M; Ghosh SS; Shafiqa A; Shukla VK; Chopra KS; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):30-3. PubMed ID: 3957487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability studies with Digoxin-Sandoz and Lanoxin.
    Beveridge T; Kalberer F; Nüesch E; Schmidt R
    Eur J Clin Pharmacol; 1975 Jun; 8(5):371-6. PubMed ID: 1243983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparative bioavailability of Lanoxin tablets and Lanoxicaps with and without sorbitol.
    O'Grady J; Johnson BF; Bye C; French J
    Eur J Clin Pharmacol; 1978 Dec; 14(5):357-60. PubMed ID: 729628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bioavailability of digoxin tablets in cardiac insufficiency patients].
    Kholodov LE; Grigor'eva EA; Glezer MG; Sabel'nikova EA
    Kardiologiia; 1980 Oct; 20(10):68-73. PubMed ID: 7441963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National underuse of anti-thrombotic therapy in chronic atrial fibrillation identified from digoxin prescribing.
    Mahmud A; Bennett K; Okechukwu I; Feely J
    Br J Clin Pharmacol; 2007 Nov; 64(5):706-9. PubMed ID: 17555462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the absorption and activity onset of -mehyl-digoxin in patients with atrial fibrillation].
    Limbourg P; Just H; Fiegel P; Michaelis J; Rosellen E
    Arzneimittelforschung; 1973 Jan; 23(1):60-3. PubMed ID: 4740697
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative study of the absorption, plasma levels, and urinary excretion of the "new" and the "old" Lanoxin.
    Falch D; Teien A; Bjerkelund CJ
    Br Med J; 1973 Mar; 1(5855):695-7. PubMed ID: 4694690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of digitalis glycosides in atrial fibrillation].
    Knez A; Haberl R; Steinbeck G
    Z Kardiol; 1994; 83 Suppl 5():71-3. PubMed ID: 7846948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A two compartment open model for digoxin pharmacokinetics in patients receiving a wide range of digoxin doses.
    Rabkin SW; Grupp G
    Acta Cardiol; 1975; 30(5):343-51. PubMed ID: 1082700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experience with the treatment of atrial fibrillation with cordarone and digoxin].
    Gligan LI; Ol' IV; Shmeleva LA
    Klin Med (Mosk); 1990 Feb; 68(2):46-8. PubMed ID: 2335945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study on digoxin tablets with high bioavailability (author's transl)].
    Flasch CI; Heinz N
    Arzneimittelforschung; 1979; 29(6):961-4. PubMed ID: 582792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood digoxin level and digitalization].
    Chavaz A; Balant L; Fabre J
    Schweiz Med Wochenschr; 1974 Jan; 104(3):65-74. PubMed ID: 4810264
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cardiac findings in atrial fibrillation and sinus rhythm. Should long-term digoxin therapy be withdrawn in atrial fibrillation?].
    Serup J; Hartling L; Ovesen J
    Ugeskr Laeger; 1983 Jun; 145(26):2025-6. PubMed ID: 6612825
    [No Abstract]   [Full Text] [Related]  

  • 18. Discordances of digoxin.
    Vaisrub S
    JAMA; 1973 Apr; 224(2):243-4. PubMed ID: 4739498
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of paroxysmal atrial fibrillation. Cardiac glycosides alone or combined with anti-arrhythmia agents?].
    Steinbeck G; Doliwa R; Bach P
    Dtsch Med Wochenschr; 1988 Dec; 113(48):1867-71. PubMed ID: 3143539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical decision analysis modeling: short-term control of ventricular response rate in atrial fibrillation or atrial flutter-digoxin versus diltiazem.
    Gonzalez ER; Ornato JP; Lawson CL
    Pharmacotherapy; 1994; 14(4):446-51. PubMed ID: 7937281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.